Atherosclerotic Cardiovascular Disease Risk Profile of Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate

BACKGROUND: In human immunodeficiency virus (HIV) treatment, tenofovir alafenamide (TAF) is associated with greater increases in all fasting cholesterol subgroups compared with tenofovir disoproxil fumarate (TDF). Because lipid abnormalities may contribute to cardiovascular morbidity and mortality,...

Descripción completa

Detalles Bibliográficos
Autores principales: Huhn, Gregory D, Shamblaw, David J, Baril, Jean-Guy, Hsue, Priscilla Y, Mills, Brittany L, Nguyen-Cleary, Thai, McCallister, Scott, Das, Moupali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2019
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6954396/
https://www.ncbi.nlm.nih.gov/pubmed/31950070
http://dx.doi.org/10.1093/ofid/ofz472

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6954396/
https://www.ncbi.nlm.nih.gov/pubmed/31950070
http://dx.doi.org/10.1093/ofid/ofz472

Ejemplares similares